HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ren-Ke Li Selected Research

Cell- and Tissue-Based Therapy (Cell Therapy)

1/2021Age-related defects in autophagy alter the secretion of paracrine factors from bone marrow mononuclear cells.
11/2018Sirtuin3 protects aged human mesenchymal stem cells against oxidative stress and enhances efficacy of cell therapy for ischaemic heart diseases.
10/2018Emerging roles of extracellular vesicles in cardiac repair and rejuvenation.
7/2015Uterine-derived progenitor cells are immunoprivileged and effectively improve cardiac regeneration when used for cell therapy.
11/2014Transforming the promise of pluripotent stem cell-derived cardiomyocytes to a therapy: challenges and solutions for clinical trials.
1/2014The promise and challenges of cardiac stem cell therapy.
10/2012Tissue inhibitor of matrix metalloproteinase-3 or vascular endothelial growth factor transfection of aged human mesenchymal stem cells enhances cell therapy after myocardial infarction.
1/2012Inhibiting matrix metalloproteinase by cell-based timp-3 gene transfer effectively treats acute and chronic ischemic cardiomyopathy.
12/2010Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair.
8/2010The effect of age on the efficacy of human mesenchymal stem cell transplantation after a myocardial infarction.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ren-Ke Li Research Topics

Disease

58Myocardial Infarction
01/2021 - 06/2002
39Infarction (Infarctions)
10/2021 - 06/2002
30Cicatrix (Scar)
01/2021 - 09/2003
20Heart Failure
11/2020 - 02/2003
8Cardiomyopathies (Cardiomyopathy)
01/2017 - 02/2003
7Heart Diseases (Heart Disease)
10/2020 - 03/2005
7Ischemia
01/2017 - 06/2002
6Stroke (Strokes)
01/2022 - 06/2002
6Inflammation (Inflammations)
01/2019 - 08/2005
5Reperfusion Injury
12/2018 - 06/2002
5Hypoxia (Hypoxemia)
01/2018 - 03/2002
5Hypertrophy
08/2016 - 10/2004
5Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
01/2006 - 06/2002
4Hyperplasia
01/2018 - 04/2004
4Myocardial Ischemia (Ischemic Heart Diseases)
10/2016 - 06/2005
4Vascular Diseases (Vascular Disease)
08/2005 - 04/2002
4Atherosclerosis
02/2004 - 04/2002
3Fibrosis (Cirrhosis)
02/2019 - 01/2013
3Neoplasms (Cancer)
10/2016 - 03/2013
3Left Ventricular Dysfunction
03/2014 - 12/2007
3Ventricular Remodeling
01/2014 - 04/2008
3Insulin Resistance
10/2013 - 08/2003
3Obesity
01/2013 - 04/2004
3Vascular System Injuries
03/2007 - 02/2004
3Cardiovascular Diseases (Cardiovascular Disease)
03/2005 - 08/2002
3Hyperglycemia
04/2003 - 06/2002
2Cardiac Arrhythmias (Arrythmia)
11/2020 - 01/2020
2Wounds and Injuries (Trauma)
01/2020 - 01/2008
2Neoplasm Metastasis (Metastasis)
10/2016 - 03/2013
2Cardiomegaly (Heart Hypertrophy)
03/2014 - 02/2006
2Necrosis
01/2013 - 07/2010
2Neointima
09/2006 - 03/2004
1Macular Degeneration (Age-Related Maculopathy)
01/2022
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022
1Cognitive Dysfunction
02/2020
1Immune System Diseases (Immune Disorders)
01/2020
1Glioblastoma (Glioblastoma Multiforme)
02/2019
1Liver Cirrhosis (Hepatic Cirrhosis)
02/2019

Drug/Important Bio-Agent (IBA)

13Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018 - 04/2004
11Proteins (Proteins, Gene)FDA Link
01/2020 - 01/2002
11CollagenIBA
01/2020 - 02/2003
8HydrogelsIBA
11/2020 - 01/2011
8Matrix Metalloproteinases (MMPs)IBA
02/2019 - 02/2003
8CytokinesIBA
01/2019 - 05/2005
7Tissue Inhibitor of Metalloproteinase-3IBA
01/2014 - 02/2003
6Biocompatible Materials (Biomaterials)IBA
01/2022 - 01/2011
6C-Reactive ProteinIBA
02/2004 - 04/2002
4ElastinIBA
10/2012 - 12/2003
4Nitric Oxide (Nitrogen Monoxide)FDA Link
08/2005 - 06/2002
3Transcription Factors (Transcription Factor)IBA
02/2019 - 10/2016
3Messenger RNA (mRNA)IBA
01/2018 - 01/2002
3Small Interfering RNA (siRNA)IBA
10/2016 - 03/2013
3Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
04/2016 - 11/2007
3Stem Cell FactorIBA
12/2012 - 11/2005
3Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA
09/2007 - 07/2006
3Insulin-Like Growth Factor I (IGF-1)IBA
08/2005 - 01/2002
2MicroRNAs (MicroRNA)IBA
01/2020 - 10/2013
2GelatinIBA
01/2020 - 12/2002
2PolymersIBA
01/2020 - 08/2015
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2019 - 11/2016
2Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
12/2018 - 05/2010
2matrigelIBA
11/2015 - 06/2011
2Caspase 3 (Caspase-3)IBA
01/2015 - 12/2004
2AntagomirsIBA
01/2014 - 10/2013
2Glucose (Dextrose)FDA LinkGeneric
10/2013 - 01/2008
2Dinoprostone (PGE2)FDA Link
09/2013 - 04/2008
2NF-kappa B (NF-kB)IBA
01/2013 - 12/2003
2Hormones (Hormone)IBA
01/2013 - 08/2003
2ChloridesIBA
01/2008 - 11/2007
2LeptinIBA
02/2006 - 04/2004
2Metalloproteases (Metalloproteinases)IBA
01/2006 - 03/2005
2DisintegrinsIBA
01/2006 - 03/2005
2Technetium Tc 99m Sestamibi (Cardiolite)FDA LinkGeneric
08/2005 - 01/2003
2sapropterin (tetrahydrobiopterin)FDA Link
08/2005 - 06/2002
2Rosiglitazone (Avandia)FDA Link
03/2004 - 04/2003
2Complement System Proteins (Complement)IBA
02/2004 - 07/2003
2Arginine (L-Arginine)FDA Link
06/2002 - 03/2002
2Trypan BlueFDA Link
06/2002 - 06/2002
2Endothelin-1 (Endothelin 1)IBA
06/2002 - 06/2002
2Bosentan (Tracleer)FDA Link
06/2002 - 04/2002
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
10/2021
1Biopolymers (Biopolymer)IBA
11/2020
1Hematoxylin (Haematoxylon)IBA
02/2019
1cyclopamineIBA
02/2019
1Eosine Yellowish-(YS) (Eosin)IBA
02/2019
1Transforming Growth Factors (Transforming Growth Factor)IBA
02/2019
1Thioacetamide (Thioacetamid)IBA
02/2019
1insulin-like growth factor binding protein-related protein 1IBA
02/2019

Therapy/Procedure

29Transplantation
10/2021 - 06/2002
27Therapeutics
01/2022 - 06/2003
19Cell Transplantation
10/2020 - 09/2002
12Ligation
01/2015 - 09/2002
11Cell- and Tissue-Based Therapy (Cell Therapy)
01/2021 - 05/2009
4Microbubbles
02/2019 - 07/2009
3Injections
01/2018 - 01/2011
2Radiotherapy
02/2020 - 03/2013
2Absorbable Gelatin Sponge
10/2010 - 06/2002
2Bone Marrow Transplantation (Transplantation, Bone Marrow)
08/2008 - 03/2008
1Stem Cell Transplantation
10/2020
1Aftercare (After-Treatment)
02/2020